Tone mix
Week by week 52 weeks
Share of Jazz Pharmaceuticals, Inc.'s 206 headlines over the last 52 weeks by the model's call, and the same mix week by week.
Biggest swings in the last year
The weeks whose tone moved furthest from the 8-week average, with the story most outlets carried that week.
- Week of Oct 13, 2025 · tone -100Zacks Research Has Negative Outlook of JAZZ Q3 Earnings-155
- Week of Sep 1, 2025 · tone +100Jazz Pharmaceuticals (NASDAQ:JAZZ) Price Target Raised to $151.00+70
- Week of Jan 5, 2026 · tone +100Jazz Pharmaceuticals' Drug Extends Survival Past Two Years in Advanced Stomach Cancer Trial+65
- Week of Sep 15, 2025 · tone +100Jazz Pharmaceuticals plc (JAZZ) Wins FDA Nod for Modeyso in Rare Pediatric Brain Tumors+59
- Week of Oct 5, 2026 · tone -33Jazz Pharmaceuticals (NASDAQ:JAZZ) Stock Price Target Lowered at Royal Bank Of Canada-59
- Week of Apr 13, 2026 · tone 0Jazz Pharmaceuticals to Present Xywav Narcolepsy Data at 2026 AAN Annual Meeting-57
Daily headline tone, last 90 sessions
Hover a session for its totals; click to pin.
Each point is the average score of the headlines about Jazz Pharmaceuticals, Inc. in one trading session, with the 8-session average drawn through it. Sessions with no headline about the company have no point.
Tone by period
Show the table · 3 rows, 3 columns
Scroll sideways to compare all columns. Select a heading to sort.
| Last 7 sessions | 3 | +66 |
| Last 30 sessions | 14 | +40 |
| Last 90 sessions | 58 | +30 |
No matching rows. Clear the filter to see all records.
Every headline in the period counts equally.
Headlines on Wednesday, October 28, 2026
1 headline, average tone +100: 1 positive, 0 neutral and 0 negative. Showing all 1.
- www.fool.com · 1 outletWhere Will Jazz Pharmaceuticals Be in 5 Years? Oncology Is Becoming Its Growth EnginePositive
Show the table · 1 row, 4 columns
Scroll sideways to compare all columns. Select a heading to sort.
| Where Will Jazz Pharmaceuticals Be in 5 Years? Oncology Is Becoming Its Growth Engine | www.fool.com | 1 | Positive |
No matching rows. Clear the filter to see all records.
Headlines on Monday, October 26, 2026
2 headlines, average tone +50: 1 positive, 1 neutral and 0 negative. Showing all 2.
- www.rttnews.com · 2 outletsJazz Pharmaceuticals Reports Positive Phase 3 Results For Ziihera CombinationPositive
- www.themarketsdaily.com · 1 outlet2,594 Jazz Pharmaceuticals PLC $JAZZ Shares Sold by Pinnacle Associates Ltd.Neutral
Show the table · 2 rows, 4 columns
Scroll sideways to compare all columns. Select a heading to sort.
| Jazz Pharmaceuticals Reports Positive Phase 3 Results For Ziihera Combination | www.rttnews.com | 2 | Positive |
| 2,594 Jazz Pharmaceuticals PLC $JAZZ Shares Sold by Pinnacle Associates Ltd. | www.themarketsdaily.com | 1 | Neutral |
No matching rows. Clear the filter to see all records.
Headlines on Wednesday, October 14, 2026
1 headline, average tone +100: 1 positive, 0 neutral and 0 negative. Showing all 1.
- www.aol.com · 1 outletJazz Pharmaceuticals gets Cramer's vote of confidencePositive
Show the table · 1 row, 4 columns
Scroll sideways to compare all columns. Select a heading to sort.
| Jazz Pharmaceuticals gets Cramer's vote of confidence | www.aol.com | 1 | Positive |
No matching rows. Clear the filter to see all records.
Headlines on Monday, October 12, 2026
2 headlines, average tone +49: 1 positive, 1 neutral and 0 negative. Showing all 2.
- www.cnbc.com · 1 outletCramer's lightning round: 'I'm going to say yes to Jazz Pharmaceuticals'Positive
- www.tickerreport.com · 1 outletCritical Analysis: vTv Therapeutics (NASDAQ:VTVT) and Jazz Pharmaceuticals (NASDAQ:JAZZ)Neutral
Show the table · 2 rows, 4 columns
Scroll sideways to compare all columns. Select a heading to sort.
| Cramer's lightning round: 'I'm going to say yes to Jazz Pharmaceuticals' | www.cnbc.com | 1 | Positive |
| Critical Analysis: vTv Therapeutics (NASDAQ:VTVT) and Jazz Pharmaceuticals (NASDAQ:JAZZ) | www.tickerreport.com | 1 | Neutral |
No matching rows. Clear the filter to see all records.
Headlines on Friday, October 9, 2026
1 headline, average tone -100: 0 positive, 0 neutral and 1 negative. Showing all 1.
- www.dailypolitical.com · 1 outletJazz Pharmaceuticals (NASDAQ:JAZZ) Stock Price Target Lowered at Royal Bank Of CanadaNegative
Show the table · 1 row, 4 columns
Scroll sideways to compare all columns. Select a heading to sort.
| Jazz Pharmaceuticals (NASDAQ:JAZZ) Stock Price Target Lowered at Royal Bank Of Canada | www.dailypolitical.com | 1 | Negative |
No matching rows. Clear the filter to see all records.
How the score works
A headline's tone is not a forecast of the share price. Read the headlines themselves before acting on an average.
Which headlines count
Headlines come from the GDELT global news feed from 2019-09-23 on. A headline counts only when a model judges it to be about Jazz Pharmaceuticals, Inc., not a passing mention.
How each headline is scored
The model calls each headline positive, neutral or negative news for the company. A period's tone is the share of positive minus negative headlines, from -100 (all negative) to +100 (all positive).
When a headline counts
Headlines published by 9:15 a.m. New York time belong to that day's session. Later and weekend headlines move to the next trading session.
Repeated stories
When several outlets carry the same headline, it counts once per session.